NEW YORK (GenomeWeb) – Genetic Technologies said today that it regained compliance with a listing requirement for continued listing on the Nasdaq, while the exchange has extended a deadline for the company to regain compliance with another requirement. 

In August Nasdaq sent a letter to Genetic Technologies informing the firm that it wasn't in compliance with a Nasdaq listing rule calling for a minimum $1 bid on the company's shares, and as a result the firm faced a possible delisting action. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.